by Virtus | May 3, 2026 | Respiratory Preclinical Research
Designing preclinical respiratory studies is a critical step in respiratory drug development, as study design directly influences data quality, reproducibility, and translational relevance. Preclinical respiratory studies are used to evaluate therapeutic candidates in...
by Virtus | May 3, 2026 | Early-Stage Respiratory Drug Development
Respiratory CRO services support biotech and pharmaceutical companies developing therapies for asthma, COPD, and viral respiratory diseases by delivering specialist preclinical respiratory studies. A respiratory preclinical CRO provides disease-specific models, in...
by Virtus | Apr 11, 2026 | Respiratory Preclinical Research
Preclinical efficacy testing respiratory programmes are used to evaluate whether a therapeutic candidate produces a measurable biological effect in respiratory disease models. These studies are a critical step in respiratory drug development, providing data on...
by Virtus | Apr 11, 2026 | Early-Stage Respiratory Drug Development
Outsourcing vs in-house respiratory research is a common consideration for biotech and pharmaceutical companies developing therapies for asthma, COPD, and viral respiratory diseases. Respiratory drug development requires specialised preclinical models, in vivo...
by Virtus | Apr 11, 2026 | Viral & Rhinovirus Models
Viral challenge preclinical studies are used in respiratory preclinical research to evaluate how therapeutic candidates perform under controlled viral infection conditions. These studies are commonly applied in respiratory drug development to investigate antiviral...
